two immunophenotypes were recorded, CD45 - CD38+CD138+CD19-CD56+ and CD45 - CD38+CD138+CD19-CD56 - accounting for the highest proportion of 42.9% and 38, 1% respectively, and at the same time recorded a rather high rate of 47.6% of cases without CD56 expression.